Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZFHX3 antisense RNA 2 (ZFHX3-AS2) is an antisense long non-coding RNA transcribed from the opposite DNA strand of the Zinc finger homeobox 3 (ZFHX3) gene locus. While the parent gene ZFHX3 encodes a large transcription factor with vital biological roles in neuronal differentiation, circadian rhythm maintenance, cardiac function, cancer, and immune response[4][3][1][2][5], no functional data or disease associations are documented for ZFHX3-AS2 in major databases or peer-reviewed sources. Its structure presumably enables potential regulatory effects on ZFHX3 gene expression, but direct biological functions, disease relevance, or potential as a therapeutic target remain unknown due to the lack of explicit information in the literature. The entry "ZFHX3-AS2" appears to be either novel, under-characterized, or not commonly recognized as a distinct therapeutic target. Key points: - ZFHX3-AS2 is not established as a canonical therapeutic target. - No concrete alias, function, drug interaction, or disease role data is available. - Most well-documented data pertains to the protein-coding ZFHX3 gene, not to this antisense transcript[4][5][1][3]. If research requires structured information on ZFHX3 itself (the protein-coding transcription factor), robust data is available; for ZFHX3-AS2, data is insufficient and the entry should be flagged for lack of evidence.
None described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZFHX3 antisense RNA 2 (ZFHX3-AS2).